Beijing, China

Hongjun Ren


 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:

goldMedal1 out of 832,680 
Other
 patents

Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):

Title: Innovations of Hongjun Ren in Anticancer Drug Development

Introduction

Hongjun Ren is a notable inventor based in Beijing, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of anticancer drugs. His innovative work has led to the creation of a unique compound that shows promise in cancer treatment.

Latest Patents

Hongjun Ren holds 1 patent for his invention titled "Spirocyclic indolone polyethylene glycol carbonate compound, composition, preparation method and use thereof." This invention relates to a spirocyclic indolone polyethylene glycol carbonate compound that exhibits antitumor activity. The compound is characterized by excellent tumor inhibitory activity, water solubility, and low toxicity, making it suitable for intravenous injection.

Career Highlights

Throughout his career, Hongjun Ren has worked with various organizations, including Jiangsu Yayo Biotechnology Co., Ltd. His expertise in the field has allowed him to contribute to advancements in drug development and therapeutic applications.

Collaborations

Hongjun Ren has collaborated with notable colleagues such as Jie Ma and Fei Xiao. Their combined efforts have furthered research and innovation in the field of anticancer therapies.

Conclusion

Hongjun Ren's contributions to the development of anticancer drugs highlight his innovative spirit and dedication to improving healthcare. His work continues to inspire advancements in medicinal chemistry and cancer treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…